Skip to main content
logo
YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
5.88
-0.27 (-4.39%)
Oct 7, 2026, 4:00 PM EDT - Market closed

YD Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
1.240.60.510.350.36
Revenue Growth
147.92%16.94%45.76%-3.84%-
Gross Profit
0.370.170.160.150.13
Operating Income
-6.55-5.27-1.46-0.01-0.04
Net Income
0.31-8.31-1.410.01-0.05
Earnings Per Share
0.00-0.12-0.020.00-
EPS Growth
-----

Revenue by Segment
Chart
Fiscal YearFY 2025FY 2024
Period EndingDec '25 Dec '24
Sales of Medical and Other Related Products Segment
0.560.51
Research and Development of Sales of Contact Lenses
0.04-
Total
0.60.51

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
2.666.013.130.090.03
Total Debt
0.010.010.020.050.12
Net Cash (Debt)
2.6663.110.04-0.09
Net Cash Growth
-14.57%92.95%7769.12%--
Net Cash Per Share
0.040.090.050.00-

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-7.26-6.6-1.22-0.060.07
Capital Expenditures
-1.45-1.44-0.07-0-
Free Cash Flow
-8.7-8.04-1.3-0.060.07
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
29.60%28.05%30.44%43.82%36.58%
Operating Margin
-528.73%-883.31%-286.45%-2.81%-12.33%
Pretax Margin
24.67%-1392.86%-271.67%5.04%-13.30%
Profit Margin
24.67%-1392.61%-276.58%3.87%-13.95%
FCF Margin
-702.15%-1346.60%-254.25%-15.98%19.21%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
1362.13--3497.13-
P/FCF Ratio
----720.26
PS Ratio
336.061436.2888.92135.44138.36